Brisbane Times
·general
·5 hours ago
‘Unviable’: 450,000 Australians to miss out on subsidised weight loss drug
Eli Lilly's decision not to subsidize its Mounjaro weight loss drug means an estimated 450,000 Australians with Type 2 diabetes will miss out. The Pharmaceutical Benefits Advisory Committee noted patients need more effective treatments but acknowledged the conditions proposed to Eli Lilly were deemed unviable. The outcome may hinder future listings for other conditions needing affordable medication.
Summary by Glance · Brisbane Times
Next
Loving doing this? 🎉
Take it further — get the full app and never miss a moment of what's happening in Australia.
Breaking news alerts
Instant lock-screen notifications the moment big stories break across Australia.
Australian news & events
Politics, sport, weather, local events — all in one swipeable feed, updated around the clock.
Stay ahead of the news cycle
30-second summaries so you're always informed, even on your busiest days.
Loading article…
This publisher's site can't be shown here due to their security settings.
Open full article →No source link available for this article.
✨
Ask AI